SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Hippieslayer who wrote (19996)5/4/1998 1:14:00 PM
From: Andreas Helke  Read Replies (2) | Respond to of 32384
 
Ligand may follow in Entremeds footsteps and double over night once we hear promising results from the breast cancer clinical trials. This of course requires that cancer treatments other then anti angiogenesis will still be considered to be promising.

Andreas